mlsanityData to 14 Oct 2026

CAi Copilot: Reducing Operational Workload in Molecular Design through Intent-Driven Agentic Workflows

arXiv 2608.06961 ↗First posted 7 Aug 2026cs.AI cs.LGcited by 1

On the map: LLM agents and tool use → Medical and scientific domain agents

Abstract (arXiv)

Early-stage molecular design is an iterative process, not just a task of generating molecules. Researchers turn broad goals into design strategies, refine candidates, assess many properties, and gather evidence before synthesis and tests. AI methods can generate molecules, optimize several goals, predict properties, dock compounds, and account for synthesis. Yet these functions are spread across specialized tools. Experts must still coordinate each step, judge interim results, and integrate evidence. The central challenge is thus to turn research intent into adaptive, traceable runs grounded in scientific tools. We cast this challenge as intent-to-evidence molecular design workflow execution and present CAi Copilot, an expert-oriented agent with three linked layers. The Research Interface Layer turns intent into an executable plan. The Agent Reasoning Layer uses interim results to guide each run. The Execution Substrate supplies molecular tools, metrics, reusable utilities, and backend services. Across 45 tasks, CAi achieves the strongest overall performance, with an outcome score of 84.59, exceeding the next-best result by 18.07 points. Additional benchmarks test how CAi coordinates generation, screening, and multi-criteria evaluation, while exposing limits in long-horizon execution. These results show that CAi turns broad molecular-design intent into transparent, traceable workflows that connect interim decisions to candidate-level evidence.

Key facts. Cited by 1 paper in the map (data through 14 Oct 2026). Placed in Medical and scientific domain agents, one of 16 directions in LLM agents and tool use. Builds on 17 of its 33 references that are in the map. First posted on arXiv 7 Aug 2026.

Builds on

17 of 33 references.

Closest ancestors · 3

Same direction, newest first

  1. 2026SMDD-Bench: Can LLMs Solve Real-World Small Molecule Drug Design Tasks?20 May
  2. 2025Large Language Model Agent for Modular Task Execution in Drug Discovery26 Jun
  3. 2025TxAgent: An AI Agent for Therapeutic Reasoning Across a Universe of Tools14 Mar

Other references · 14

  1. 2023ChemCrow: Augmenting large-language models with chemistry toolscited by 631
  2. 2025Accelerating scientific discovery with Co-Scientistcited by 401
  3. 2022Pocket2Mol: Efficient Molecular Sampling Based on 3D Protein Pocketscited by 183
  4. 2022Translation between Molecules and Natural Languagecited by 177
  5. 2023Mol-Instructions: A Large-Scale Biomolecular Instruction Dataset for Large Language Modelscited by 133
  6. 2024LlaSMol: Advancing Large Language Models for Chemistry with a Large-Scale, Comprehensive, High-Quality Instruction Tuning Datasetcited by 128
  7. 2024ChemLLM: A Chemical Large Language Modelcited by 106
  8. 2024DecompDiff: Diffusion Models with Decomposed Priors for Structure-Based Drug Designcited by 88
  9. 2025An AI system to help scientists write expert-level empirical softwarecited by 60
  10. 2024RGFN: Synthesizable Molecular Generation Using GFlowNetscited by 41
  11. 2024SynFlowNet: Design of Diverse and Novel Molecules with Synthesis Constraintscited by 26
  12. 2025LIDDIA: Language-based Intelligent Drug Discovery Agentcited by 24
2 more
  1. 2023Generation of 3D Molecules in Pockets via Language Modelcited by 13
  2. 2026MolClaw: An Autonomous Agent with Hierarchical Skills for Drug Molecule Evaluation, Screening, and Optimizationcited by 7

Built on by

Cited by year (2026 to 14 Oct)

Citing papers per year: 2026: 1.

1 paper.

Similar, not cited

Close in wording, no citation either way

  1. 2026Molecular LLM Agents: From Architectural Design to Scientific Autonomy
  2. 2026Logos: An evolvable reasoning engine for rational molecular design
  3. 2026From Benchmark to Bench: Can Agents Survive Real-World Drug Discovery?
  4. 2026Navigating Route Latent Space for Synthesizable Molecular Design
  5. 2026MolDesignBench: Evaluating LLM-based Agent for Scenario-grounded Molecular Design
  6. 2026M3OS: A Monte Carlo Graph Search-Orchestrated Multi-Agent LLM System for Evidence-Traced Molecular Optimization
  7. 2026Mol-Debate: Multi-Agent Debate Improves Structural Reasoning in Molecular Design
  8. 2024AgentDrug: Utilizing Large Language Models in An Agentic Workflow for Zero-Shot Molecular Editing